NCT02081326View on ClinicalTrials.gov

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2031

Conditions
Diabetes Mellitus, Type OneDiabetes Mellitus, Type IAutoimmune DiabetesCovid19
Interventions
BIOLOGICAL

Bacillus Calmette-Guérin

2 BCG vaccinations spaced 4 weeks apart during the first year and then 1 vaccination every year for the next 4 years

BIOLOGICAL

Saline injection

2 injections spaced 4 weeks apart during the first year, then 1 injection per year for the next 4 years

Trial Locations (1)

02129

Immunobiology Labs CNY 149, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER